On June 22, 2026, Hims and Hers Health Inc (HIMS) shares fell 5.4% today, trading at $33.54. Over the past 52 weeks, the stock has ranged from a low of $13.74 to
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Hims & Hers Health Inc. (NYSE:HIMS) shares are climbing after Barclays reiterated its bullish stance and lifted its price target from $29 to $39. Here's what you need to know.
TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.

Hims & Hers: The Bull Case Remains Strong

06:33am, Thursday, 18'th Jun 2026
Hims & Hers remains attractive at $33, supported by renewed Novo Nordisk partnership and unique access to patient demand. Despite weak Q1 2026 results—4% revenue growth, declining margins, and a net
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $31.89, moving +1.33% from the previous trading session.

Hims & Hers Enters A New Phase

06:08pm, Tuesday, 16'th Jun 2026
The Novo Nordisk partnership transformed Hims & Hers Health, Inc. from a fringe obesity player into an official healthcare ecosystem participant. Short interest remains elevated near 30%-32% of the HI
Hims & Hers Health Inc. (NYSE:HIMS) shares are trading lower on Friday as the stock digests last week's chief medical officer appointment and gives back some recent "repair rally" gains, even while ma
Scott Galloway and Ed Elson laid out the math on Prof G Markets and it should make every fast food shareholder uneasy: roughly 30 million Americans, about 1 in 8 US adults, are now on GLP-1s, and the
Hims & Hers Health, Inc. (HIMS) closed at $27.71 in the latest trading session, marking a -4.38% move from the prior day.
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks is more attractive to value investors?
Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock?
On June 08, 2026, Hims and Hers Health Inc (HIMS) shares rose 3.7% today to a current price of $27.17. The stock has traded within a 52-week range of $13.74 to $7
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
This telehealth stock has fallen hard, but its GLP-1 shift and global expansion could reshape the long-term story. Is the market too skeptical or still too optimistic?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE